Skip to content

Biodesix, Inc. BDSX Long-Term Debt

Long-Term Debt at other companies

Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$124.75M-5.2%
GeneDx Holdings logo
GeneDx HoldingsWGS
$96.73M+86.8%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$802.9M-33.1%
Quest Diagnostics logo
Quest DiagnosticsDGX
$5.16B-12.0%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$2.66B+6.1%
Guardant Health logo
Guardant HealthGH

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermNotesPayable.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s long-term debt?
Biodesix, Inc. (BDSX) reported long-term debt of $46.49M in Q1 2026.
How has Biodesix, Inc.'s long-term debt changed year-over-year?
Biodesix, Inc.'s long-term debt increased by 26.7% year-over-year, from $36.69M to $46.49M.
What is the long-term trend for Biodesix, Inc.'s long-term debt?
Over 5 years (2020 to 2025), Biodesix, Inc.'s long-term debt has grown at a 24.4% compound annual growth rate (CAGR), from $15.93M to $47.45M.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.